Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes.
暂无分享,去创建一个
[1] S. Gogolewski,et al. BIODEGRADABLE MATERIALS OF POLYLACTIDES, .4. POROUS BIOMEDICAL MATERIALS BASED ON MIXTURES OF POLYLACTIDES AND POLYURETHANES , 1982 .
[2] A. Takahara,et al. Effect of soft segment chemistry on the biostability of segmented polyurethanes. II. In vitro hydrolytic degradation and lipid sorption. , 1992, Journal of biomedical materials research.
[3] C. G. Pitt,et al. Modification of the rates of chain cleavage of poly(ϵ-caprolactone) and related polyesters in the solid state , 1987 .
[4] F. Tan,et al. Ionic Interactions of Polyurethanes , 1988, Journal of biomaterials applications.
[5] Sylwester Gogolewski,et al. Biodegradable polyurethanes for implants. II. In vitro degradation and calcification of materials from poly(epsilon-caprolactone)-poly(ethylene oxide) diols and various chain extenders. , 2002, Journal of biomedical materials research.
[6] D J Wheatley,et al. Polyurethane heart valves: fatigue failure, calcification, and polyurethane structure. , 1997, Journal of biomedical materials research.
[7] James P. Braselton,et al. Technology and Applications , 1997 .
[8] J. A. Hubbell,et al. Rapidly degraded terpolymers of dl-lactide, glycolide, and epsilon-caprolactone with increased hydrophilicity by copolymerization with polyethers. , 1990, Journal of biomedical materials research.
[9] S. Gogolewski,et al. Polyurethane vascular prostheses in pigs , 1987 .
[10] D. Han,et al. In vivo biostability and calcification-resistance of surface-modified PU-PEO-SO3. , 1993, Journal of biomedical materials research.
[11] S. Gogolewski,et al. Novel Biodegradable Polyurethanes for Medical Applications , 2000 .
[12] J. Andrade,et al. Calcification of nontextured implantable blood pumps. , 1981, Transactions - American Society for Artificial Internal Organs.
[13] R. J. Thoma. Poly(ether) Urethane Reactivity with Metal-Ion in Calcification and Environmental Stress Cracking , 1986, Journal of biomaterials applications.
[14] G. Golomb. Calcification of polyurethane-based biomaterials implanted subcutaneously in rats: role of porosity and fluid absorption in the mechanism of mineralization , 1992 .
[15] S. Gogolewski. Liquid-induced crystallization and annealing of polyester-urethane elastomers , 1978 .
[16] C. S. Schollenberger,et al. Thermoplastic Polyurethane Hydrolysis Stability , 1971 .
[17] T. Yamamuro,et al. Apatite coated on organic polymers by biomimetic process: improvement in adhesion to substrate by HCl treatment , 1995 .
[18] S. Gogolewski,et al. In vitro degradation of novel medical biodegradable aliphatic polyurethanes based on ϵ-caprolactone and Pluronics® with various hydrophilicities , 2002 .
[19] S. Gogolewski,et al. Molecular stability, mechanical properties, surface characteristics and sterility of biodegradable polyurethanes treated with low-temperature plasma☆ , 2003 .
[20] Anne Hiltner,et al. Recent advances in biomedical polyurethane biostability and biodegradation , 1998 .
[21] S. Gogolewski,et al. The effect of gamma radiation on molecular stability and mechanical properties of biodegradable polyurethanes for medical applications , 2003 .
[22] J. Szivek,et al. Characterization of three formulations of a synthetic foam as models for a range of human cancellous bone types. , 1995, Journal of applied biomaterials : an official journal of the Society for Biomaterials.
[23] F. Benoit. Degradation of polyurethane foams used in the Même breast implant. , 1993, Journal of biomedical materials research.
[24] S. Gogolewski,et al. An artificial skin based on biodegradable mixtures of polylactides and polyurethanes for full-thickness skin wound covering , 1983 .
[25] R Guidoin,et al. Assessing the resistance to calcification of polyurethane membranes used in the manufacture of ventricles for a totally implantable artificial heart. , 1999, Journal of biomedical materials research.
[26] M. Okada,et al. Swelling behavior and controlled release of new hydrolyzable poly(ether urethane) gels derived from saccharide and L‐lysine derivatives and poly(ethylene glycol) , 1996 .
[27] C. Batich,et al. Toxic hydrolysis product from a biodegradable foam implant. , 1989, Journal of biomedical materials research.
[28] S. Gogolewski,et al. Polyurethane microporous membranes as pericardial substitutes , 1987 .